Literature DB >> 12365524

Syringe type and drug injector risk for HIV infection: a case study in Texas.

William A Zule1, David P Desmond, James Alan Neff.   

Abstract

Studies of accidental needlestick exposure to blood containing human immunodeficiency virus (HIV) have shown that the volume of blood in an exposure is a strong predictor of subsequent infection. Illicit drug injectors, a group at elevated risk for HIV transmission, use syringes manufactured in two styles, one of which (the integral cannula type) retains substantially less blood after intravenous use than the other (the detachable needle type). In this report, we examine some of the factors associated with use of syringes with detachable needles among drug injectors in San Antonio, Texas using data from epidemiological surveys, ethnographic studies, and historical observations. We compare personal history of syringe type use with HIV serostatus in a sample of 501 active drug injectors interviewed and screened for HIV in 1997-1998. Ninety-nine percent of these respondents reported that they currently used only integral cannula syringes, but 13% had used a syringe with a detachable needle within the past 2 years, and 37% had used one in their lifetime. Only 9% had ever used one > or = 20 times in a year. Hispanic (Mexican American) respondents were significantly less likely than other ethnic groups to have ever used a detachable needle syringe. HIV seroprevalence was < 1% among heterosexual injectors who had never used a detachable needle syringe compared to 4% among those who had used one (p<0.05).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365524     DOI: 10.1016/s0277-9536(01)00256-8

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  19 in total

1.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  HIV among injection drug users in large US metropolitan areas, 1998.

Authors:  Samuel R Friedman; Spencer Lieb; Barbara Tempalski; Hannah Cooper; Marie Keem; Risa Friedman; Peter L Flom
Journal:  J Urban Health       Date:  2005-07-13       Impact factor: 3.671

3.  Detachable low dead space syringes for the prevention of hepatitis C among people who inject drugs in Bristol, UK: an economic evaluation.

Authors:  Elizabeth Hancock; Zoe Ward; Rachel Ayres; Jane Neale; Deborah Hussey; Joanna May Kesten; Matthew Hickman; Peter Vickerman
Journal:  Addiction       Date:  2019-11-19       Impact factor: 6.526

4.  Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs.

Authors:  Christine U Oramasionwu; Terence L Johnson; William A Zule; Jessica Carda-Auten; Carol E Golin
Journal:  Am J Public Health       Date:  2015-04-16       Impact factor: 9.308

5.  The association of syringe type and syringe cleaning with HCV infection among IDUs in Budapest, Hungary.

Authors:  V Anna Gyarmathy; Alan Neaigus; Mary M Mitchell; Eszter Ujhelyi
Journal:  Drug Alcohol Depend       Date:  2008-12-05       Impact factor: 4.492

6.  Correlates of unsafe equipment sharing among injecting drug users in St. Petersburg, Russia.

Authors:  V Anna Gyarmathy; Nan Li; Karin E Tobin; Irving F Hoffman; Nikolai Sokolov; Julia Levchenko; Julia Batluk; Andrei A Kozlov; Andrei P Kozlov; Carl A Latkin
Journal:  Eur Addict Res       Date:  2009-06-05       Impact factor: 3.015

7.  Event-level analyses of sex-risk and injection-risk behaviors among nonmedical prescription opioid users.

Authors:  William A Zule; Christine Oramasionwu; Donna Evon; Sayaka Hino; Irene A Doherty; Georgiy V Bobashev; Wendee M Wechsberg
Journal:  Am J Drug Alcohol Abuse       Date:  2016-06-10       Impact factor: 3.829

8.  Usage of low dead space syringes and association with hepatitis C prevalence amongst people who inject drugs in the UK.

Authors:  Adam Trickey; Margaret T May; Vivian Hope; Zoe Ward; Monica Desai; Ellen Heinsbroek; Matthew Hickman; Peter Vickerman
Journal:  Drug Alcohol Depend       Date:  2018-09-15       Impact factor: 4.492

9.  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.

Authors:  William A Zule; Georgiy Bobashev
Journal:  Drug Alcohol Depend       Date:  2008-11-11       Impact factor: 4.492

10.  Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of England.

Authors:  Joanna M Kesten; Rachel Ayres; Jane Neale; Jody Clark; Peter Vickerman; Matthew Hickman; Sabi Redwood
Journal:  Int J Drug Policy       Date:  2016-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.